Publication | Closed Access
An international expanded-access programme of everolimus: Addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy
87
Citations
17
References
2011
Year
UrologyOncologyGenitourinary CancerCancer ManagementCancer TreatmentMedicineAddressing SafetyTumor MicroenvironmentInternational Expanded-access Programme
| Year | Citations | |
|---|---|---|
Page 1
Page 1